Anemia

Anemia is a common condition in which the body does not have enough red blood cells, or the red blood cells do not contain enough hemoglobin, the protein that carries oxygen throughout the body. This can lead to a lack of oxygen in the body, causing fatigue, weakness, and shortness of breath. In hematology and oncology research, anemia is a common complication of cancer and its treatments. Chemotherapy, radiation therapy, and surgery can all cause a decrease in red blood cells or hemoglobin levels, leading to anemia. Cancer itself can also cause anemia, as the cancer cells compete with the body's normal cells for nutrients and oxygen. Research in hematology and oncology is focused on finding ways to prevent and treat anemia in cancer patients. This includes the development of new drugs to stimulate the production of red blood cells, the use of blood transfusions to supplement red blood cell levels, and the optimization of chemotherapy and radiation therapy to minimize the risk of anemia. Additionally, research is ongoing to better understand the underlying mechanisms of anemia in cancer patients and to identify biomarkers that can predict which patients are at the highest risk of developing anemia. This will allow for earlier intervention and better management of this common complication of cancer treatment.

← Hematology Research and Oncology Research

Related Articles

2 article(s) found

Molecular Study of Hepcidin HAMP (-582A/G) Gene Polymorphisms and Measurement of Serum Hepcidin Level among Sudanese Patients with Anemia of Chronic Kidney Disease

Full-text HTML Download PDF Download XML

Prolonged survival of Diamond-Blackfan anemia and RPS19 mutation: an observation in Togo

Full-text HTML Download PDF Download XML